Journal details
MOLECULAR CANCER THERAPEUTICS
AMER ASSOC CANCER RESEARCH · ISSN 1535-7163 · eISSN 1538-8514
SCIEScopusMEDLINEPubMedPMC
Overview
MOLECULAR CANCER THERAPEUTICS is a Oncology journal published by AMER ASSOC CANCER RESEARCH (United States). Use this page to check its impact factor, JCR quartile, CAS zone and indexing before you submit. Always confirm the scope, APC and policies on the journal's official website.
Publication output
2026: 84 articles · 2025: 611 articles · 2024: 365 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of MOLECULAR CANCER THERAPEUTICS?
The impact factor recorded for MOLECULAR CANCER THERAPEUTICS is 6.9 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of MOLECULAR CANCER THERAPEUTICS?
MOLECULAR CANCER THERAPEUTICS is listed in CAS Zone 2.
Which databases index MOLECULAR CANCER THERAPEUTICS?
MOLECULAR CANCER THERAPEUTICS is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.